← Back to Search

Procedure

Abnormal Ovarian Ultrasound for Ovarian Tumors

N/A
Waitlist Available
Research Sponsored by Frederick R. Ueland, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights

Study Summary

This trial will see if using a special kind of ultrasound can help distinguish between benign and malignant ovarian tumors, potentially reducing the number of false positive results.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Positive predictive value (PPV) of ovarian cancer screening
Secondary outcome measures
Compliance to the treatment algorithm
Surgical complications

Trial Design

1Treatment groups
Experimental Treatment
Group I: Abnormal Ovarian UltrasoundExperimental Treatment1 Intervention
Abnormal Ovarian Ultrasound
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Abnormal Ovarian Ultrasound
2016
N/A
~180

Find a Location

Who is running the clinical trial?

Frederick R. Ueland, M.D.Lead Sponsor
4 Previous Clinical Trials
654 Total Patients Enrolled
Lucille P. Markey Cancer Center at University of KentuckyOTHER
3 Previous Clinical Trials
319 Total Patients Enrolled
~21 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top